Literature DB >> 7150411

Nisoldipine: a new, more selective calcium current blocker in cardiac Purkinje fibers.

R S Kass.   

Abstract

Nisoldipine is a new dihydropyridine derivative which is structurally related to the calcium current blocker nifedipine. In this paper, the effects of this new blocker are studied on Purkinje fiber plateau currents and are compared with the effects of D600 on the same currents. The results show that, like D600, at concentrations near 10 microM nisoldipine can completely block the slow inward current and contractile activation. As is the case for D600, at these concentrations, nisoldipine reduces the transient outward current. However, in contrast to D600 and other calcium current blockers, this new compound does not reduce the delayed rectifier. In addition, these experiments indicate that the block of slow inward current by nisoldipine is much less sensitive to membrane potential than is the case for the block by D600 of this current. These results show that nisoldipine is a more selective calcium current blocker than previously studied compounds and suggest that it may be useful both as an experimental and a therapeutic tool.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7150411

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  33 in total

1.  Subtype-specific reduction of voltage-gated calcium current in medium-sized dorsal root ganglion neurons after painful peripheral nerve injury.

Authors:  J B McCallum; H-E Wu; Q Tang; W-M Kwok; Q H Hogan
Journal:  Neuroscience       Date:  2011-01-28       Impact factor: 3.590

2.  Agonists Bay-K8644 and CGP-28392 open calcium channels reconstituted from skeletal muscle transverse tubules.

Authors:  H Affolter; R Coronado
Journal:  Biophys J       Date:  1985-08       Impact factor: 4.033

3.  Delayed rectification in the calf cardiac Purkinje fiber. Evidence for multiple state kinetics.

Authors:  P B Bennett; L C McKinney; R S Kass; T Begenisich
Journal:  Biophys J       Date:  1985-10       Impact factor: 4.033

4.  Hemodynamic effects of nisoldipine, a highly specific calcium antagonist, in patients with acute myocardial infarction.

Authors:  J Wilson; P J Commerford; R S Millar; L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1992-02       Impact factor: 3.727

5.  Calcium channel antagonists: pharmacological considerations.

Authors:  D Rampe; C M Su; F Yousif; D J Triggle
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

Review 6.  Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.

Authors:  H A Friedel; E M Sorkin
Journal:  Drugs       Date:  1988-12       Impact factor: 9.546

7.  Photoalteration of calcium channel blockade in the cardiac Purkinje fiber.

Authors:  M C Sanguinetti; R S Kass
Journal:  Biophys J       Date:  1984-05       Impact factor: 4.033

8.  Anion and cation modulation of the guinea-pig ventricular action potential during beta-adrenoceptor stimulation.

Authors:  P C Levesque; C D Clark; S I Zakarov; L V Rosenshtraukh; J R Hume
Journal:  Pflugers Arch       Date:  1993-06       Impact factor: 3.657

9.  Delayed rectification in the cardiac Purkinje fiber is not activated by intracellular calcium.

Authors:  R S Kass
Journal:  Biophys J       Date:  1984-04       Impact factor: 4.033

10.  Nitrendipine block of cardiac calcium channels: high-affinity binding to the inactivated state.

Authors:  B P Bean
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.